An Inflammation Loop Orchestrated by S100A9 and Calprotectin Is Critical for Development of Arthritis
Open Access
- 18 September 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (9), e45478
- https://doi.org/10.1371/journal.pone.0045478
Abstract
The S100A9 and S100A8 proteins are highly expressed by neutrophils and monocytes and are part of a group of damage-associated molecular pattern molecules that trigger inflammatory responses. Sera and synovial fluids of patients with rheumatoid arthritis (RA) contain high concentrations of S100A8/A9 that correlate with disease activity. In this study, we investigated the importance of S100A9 in RA by using neutralizing antibodies in a murine lipopolysaccharide-synchronized collagen-induced arthritis model. We also used an in vitro model of stimulation of human immune cells to decipher the role played by S100A9 in leukocyte migration and pro-inflammatory cytokine secretion. Treatment with anti-S100A9 antibodies improved the clinical score by 50%, diminished immune cell infiltration, reduced inflammatory cytokines, both in serum and in the joints, and preserved bone/collagen integrity. Stimulation of neutrophils with S100A9 protein led to the enhancement of neutrophil transendothelial migration. S100A9 protein also induced the secretion by monocytes of proinflammatory cytokines like TNFα, IL-1β and IL-6, and of chemokines like MIP-1α and MCP-1. The effects of anti-S100A9 treatment are likely direct consequences of inhibiting the S100A9-mediated promotion of neutrophil transmigration and secretion of pro-inflammatory cytokines from monocytes. Collectively, our results show that treatment with anti-S100A9 may inhibit amplification of the immune response and help preserve tissue integrity. Therefore, S100A9 is a promising potential therapeutic target for inflammatory diseases like rheumatoid arthritis for which alternative therapeutic strategies are needed.Keywords
This publication has 53 references indexed in Scilit:
- Damage-Associated Molecular Pattern S100A9 Increases Bactericidal Activity of Human Neutrophils by Enhancing PhagocytosisThe Journal of Immunology, 2011
- S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesisHepatology, 2009
- Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealedJCI Insight, 2009
- S100A9 is not essential for disease expression in an acute (K/BxN) or chronic (CIA) model of inflammatory arthritisScandinavian Journal of Rheumatology, 2009
- A review of the S100 proteins in cancerEuropean Journal of Surgical Oncology, 2008
- Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2007
- S100A8 and S100A9 activate MAP kinase and NF-κB signaling pathways and trigger translocation of RAGE in human prostate cancer cellsExperimental Cell Research, 2006
- Proinflammatory S100 proteins in arthritis and autoimmune diseaseArthritis & Rheumatism, 2004
- Induction of calprotectin release by Porphyromonasgingivalis lipopolysaccharide in human neutrophilsOral Microbiology and Immunology, 2004
- Immunisation against heterologous type II collagen induces arthritis in miceNature, 1980